Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
A biotin switch-based proteomics approach identifies 14-3-3ζ as a target of Sirt1 in the metabolic regulation of caspase-2.
Andersen JL
,
Thompson JW
,
Lindblom KR
,
Johnson ES
,
Yang CS
,
Lilley LR
,
Freel CD
,
Moseley MA
,
Kornbluth S
.
???displayArticle.abstract???
While lysine acetylation in the nucleus is well characterized, comparatively little is known about its significance in cytoplasmic signaling. Here we show that inhibition of the Sirt1 deacetylase, which is primarily cytoplasmic in cancer cell lines, sensitizes these cells to caspase-2-dependent death. To identify relevant Sirt1 substrates, we developed a proteomics strategy, enabling the identification of a range of putative substrates, including 14-3-3ζ, a known direct regulator of caspase-2. We show here that inhibition of Sirtuin activity accelerates caspase activation and overrides caspase-2 suppression by nutrient abundance. Furthermore, 14-3-3ζ is acetylated prior to caspase activation, and supplementation of Xenopus egg extract with glucose-6-phosphate, which promotes caspase-2/14-3-3ζ binding, enhances 14-3-3ζ-directed Sirtuin activity. Conversely, inhibiting Sirtuin activity promotes14-3-3ζ dissociation from caspase-2 in both egg extract and human cultured cells. These data reveal a role for Sirt1 in modulating apoptotic sensitivity, in response to metabolic changes, by antagonizing 14-3-3ζ acetylation.
Andersen,
Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2.
2009, Pubmed,
Xenbase
Andersen,
Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2.
2009,
Pubmed
,
Xenbase
Bowers,
Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
2010,
Pubmed
Brunet,
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.
2004,
Pubmed
Byles,
Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells.
2010,
Pubmed
Chen,
Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
2005,
Pubmed
Choudhary,
Lysine acetylation targets protein complexes and co-regulates major cellular functions.
2009,
Pubmed
Chu,
Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.
2005,
Pubmed
Cotelle,
14-3-3s regulate global cleavage of their diverse binding partners in sugar-starved Arabidopsis cells.
2000,
Pubmed
Datta,
14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation.
2000,
Pubmed
Forrester,
Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture.
2009,
Pubmed
Fukuda,
NADP(H) phosphatase activities of archaeal inositol monophosphatase and eubacterial 3'-phosphoadenosine 5'-phosphate phosphatase.
2007,
Pubmed
Hamaguchi,
DBC2, a candidate for a tumor suppressor gene involved in breast cancer.
2002,
Pubmed
Hao,
SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures.
2006,
Pubmed
Huffman,
SIRT1 is significantly elevated in mouse and human prostate cancer.
2007,
Pubmed
Imai,
Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases.
2010,
Pubmed
Jaffrey,
The biotin switch method for the detection of S-nitrosylated proteins.
2001,
Pubmed
Kim,
Interactions between DBC1 and SIRT 1 are deregulated in breast cancer cells.
2009,
Pubmed
Kim,
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.
2006,
Pubmed
Kim,
DBC1 is a negative regulator of SIRT1.
2008,
Pubmed
Liu,
The critical role of the class III histone deacetylase SIRT1 in cancer.
2009,
Pubmed
Liu,
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.
2006,
Pubmed
Lombard,
Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation.
2007,
Pubmed
Luo,
Negative control of p53 by Sir2alpha promotes cell survival under stress.
2001,
Pubmed
Norris,
Acetylation goes global: the emergence of acetylation biology.
2009,
Pubmed
North,
The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.
2003,
Pubmed
Nutt,
Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2.
2005,
Pubmed
,
Xenbase
Nutt,
Metabolic control of oocyte apoptosis mediated by 14-3-3zeta-regulated dephosphorylation of caspase-2.
2009,
Pubmed
,
Xenbase
Pozuelo-Rubio,
Regulation of autophagic activity by 14-3-3ζ proteins associated with class III phosphatidylinositol-3-kinase.
2011,
Pubmed
Solomon,
Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage.
2006,
Pubmed
Tanno,
Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1.
2007,
Pubmed
Wang,
Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.
2006,
Pubmed
Wang,
Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux.
2010,
Pubmed
Zerez,
Negative modulation of Escherichia coli NAD kinase by NADPH and NADH.
1987,
Pubmed
Zhang,
HDAC6 expression is correlated with better survival in breast cancer.
2004,
Pubmed
Zhao,
Regulation of cellular metabolism by protein lysine acetylation.
2010,
Pubmed
Zhao,
Negative regulation of the deacetylase SIRT1 by DBC1.
2008,
Pubmed
